Tsumura & Co 2014 AR2
The report outlines Tsumura's commitment to long-term value creation through its Kampo medicine business during fiscal year 2014. Key highlights include the expansion of its Cultivated Land under Own Management to secure a stable supply of high-quality raw material crude drugs and mitigate price volatility. The company also advanced its 'drug fostering' program to build scientific evidence for its products and continued clinical trials for TU-100 in the United States. Additionally, Tsumura highlighted its social contributions, such as agricultural vitalization through contract cultivation and maintaining a high employment rate of 3.75% for people with disabilities.
Company: Tsumura & Co
Sector: Health Care
Country: Japan
Year: 2014
Type: AR2
Pages: 82
Tsumura & Co
Annual Report
The report outlines Tsumura's commitment to long-term value creation through its Kampo medicine business during fiscal year 2014. Key highlights include the expansion of its Cultivated Land under Own Management to secure a stable supply of high-quality raw material crude drugs and mitigate price volatility. The company also advanced its 'drug fostering' program to build scientific evidence for its products and continued clinical trials for TU-100 in the United States. Additionally, Tsumura highlighted its social contributions, such as agricultural vitalization through contract cultivation and maintaining a high employment rate of 3.75% for people with disabilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Apr 1, 2013 - Mar 31, 2014
Fiscal Year
2014
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees